Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip05/01/2021 - 04/30/2025 (PI)
NIH/National Heart, Lung, and Blood Institute1R01HL157790-01
Advancement of a poxvirus inhibitor03/12/2020 - 02/28/2025 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R01AI151559-02
Antimicrobial Surface Coatings to Reduce COVID-19 Spread11/18/2020 - 08/24/2022 (Subcontract PI)
Physical Sciences, Inc. DOD Air Force
In Vitro Evaluation and Validation of the Virex Test strips and Devices01/01/2021 - 12/31/2021 (PI)
Virex Health, Inc
B-BIC RADX-Rad: Unlu (BU) Subcontract12/21/2020 - 11/30/2021 (Co-Investigator)
The Brigham and Women's Hospital, Inc. NIH NHLBI4U54HL119145-08
Genetic probing of residues involved in ebolavirus glycoprotein entry07/01/2018 - 06/30/2021 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R21AI135517-02
SBIR Phase II: High-Throughput and Scalable Nanoparticle Characterization for Life Sciences Applications08/15/2018 - 07/31/2020 (Subcontract PI)
Nanoview Diagnostics Inc. National Science FdnIIP-1831192
role for polyamines in Ebola Virus Replication02/01/2016 - 01/31/2019 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R21AI121933-02
Assessment of infection route and vulnerability of neural precursor classes to Zika virus09/30/2016 - 08/31/2018 (Multi-PI)
PI:
John H. Connor, PhDNIH/National Institute of Neurological Disorders & Stroke5R21NS101151-02
Development of Near Real-Time, Multiplexed Diagnostics for Viral Hemorrhagic Fever08/01/2011 - 07/31/2018 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R01AI096159-05
Showing 10 of 23 results.
Show All Results
Elimination of pathogenic IgE in cystic fribrosis08/01/2016 - 05/01/2018 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI5U54HL119145-05
Inclusivity and Exclusivity Testing of advanced assays for fever of unknown origin04/13/2017 - 04/12/2018 (Subcontract PI)
Becton, Dickinson and Company DOD Naval Res Lab
Point-of-Care Nanotechnology Diagnostic for Differential Fever Diagnosis10/01/2015 - 10/31/2017 (Subcontract PI)
Becton, Dickinson and Company Paul G. Allen Fdn
Biomarker Discovery03/10/2015 - 02/28/2017 (Subcontract PI)
Johns Hopkins University Applied Physics Laboratory LLC, The Ntl Intel - IARPA
I/UCRC Collaborative Research07/01/2011 - 02/28/2017 (Co-Investigator of Sub-Project / SP)
I/UCRC: Industry Memberships
Evaluation of the mechanism of action of FDA-approved compounds that show activity against ebolavirus08/18/2014 - 02/17/2017 (PI)
Department of Defense/Army Medical Research Acquisition Activity
Elimination of pathogenic IgE in cystic fribrosis02/01/2016 - 10/31/2016 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI4U54HL119145-04
Combined Viral Load and Serology Panel for Rapid POC Ebola Diagnostics03/01/2015 - 02/29/2016 (Subcontract PI)
Nexgen Arrays LLC NIH NIAID1R43AI1185254-01
Stage-Specific Inhibitors of Orthopoxviruses04/15/2011 - 03/31/2014 (PI)
NIH/National Institute of Mental Health5R03MH094169-02
Development and Characterization of Animal Models for Filoviruses02/15/2010 - 12/31/2013 (PI)
Department of Defense/Army
Microarray Processing and Analysis of Biological Samples from Non-Human Primate Models of Viral Infections and Human Clinical Samples Supporting USAMRID Grant: Identification of Biomarkers12/30/2010 - 12/29/2012 (Subcontract PI)
Harvard University DOD ARL
Control of the eIF4F Complex by Vesicular Stomatitis Virus08/01/2006 - 07/31/2009 (PI)
NIH/National Institute of Allergy & Infectious Diseases5 K22 AI64606 02
Proof of Concept Studies on a Class of Broad Spectrum Antiviral Components03/01/2008 - 02/28/2009 (PI)
Harvard University NIH NIAID